Bearish flow noted in AstraZeneca (AZN) with 10,034 puts trading, or 5x expected. Most active are Apr-25 72 puts and Apr-25 70 puts, with total ...

AstraZeneca PLC closed 16.13% short of its 52-week high of £133.88, which the company reached on September 3rd.

The AstraZeneca PLC ADR AZN shed 1.22% to $72.60 Tuesday, on what proved to be an all-around mixed trading session for the ...

J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Astrazeneca (AZN) closed the latest trading day at $76.32, indicating a -0.97% change from the previous session's end. This change lagged the S&P 500's 1.08% gain on the day. Meanwhile ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best diabetes stocks to buy according to billionaires. The WHO estimates that 422 million ...

Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor model based on the published ...

Drugmaker AstraZeneca (AZN.L), opens new tab has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, seeking to accelerate the development of its cell ...

Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor model based on the published ...